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Abstract
Natural killer (NK) cells play a critical role in controlling murine cytomegalovirus (MCMV)
and can mediate both cytokine production and direct cytotoxicity. The NK cell activation
receptor, Ly49H, is responsible for genetic resistance to MCMV in C57BL/6 mice. Recogni-
tion of the viral m157 protein by Ly49H is sufficient for effective control of MCMV infection.
Additionally, during the host response to infection, distinct immune and non-immune cells
elaborate a variety of pleiotropic cytokines which have the potential to impact viral patho-
genesis, NK cells, and other immune functions, both directly and indirectly. While the effects
of various immune deficiencies have been examined for general antiviral phenotypes, their
direct effects on Ly49H-dependent MCMV control are poorly understood. To specifically
interrogate Ly49H-dependent functions, herein we employed an in vivo viral competition
approach to show Ly49H-dependent MCMV control is specifically mediated through cyto-
toxicity but not IFNγ production. Whereas m157 induced Ly49H-dependent degranulation,
efficient cytotoxicity also required either IL-12 or type I interferon (IFN-I) which acted directly
on NK cells to produce granzyme B. These studies demonstrate that both of these distinct
NK cell-intrinsic mechanisms are integrated for optimal viral control by NK cells.
Author Summary
Natural killer (NK) cells play a crucial role in the protection of the host against viruses and
in particular herpesvirus infections. Through their activation receptors which recognize
surface ligands on target cells, NK cells can mediate direct killing (cytotoxicity) of virus-
infected cells and produce their signature cytokine IFNγ, but it is unclear to what extent
these effector arms contribute to clearance of murine cytomegalovirus (MCMV) infec-
tions. Additionally, NK cells are activated through their cytokine receptors but the inter-
play between the activation and cytokine receptor pathways has not been elucidated.
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Herein we devised a viral competition assay that allowed direct evaluation of the require-
ments for NK cell mediated MCMV control. We found that cytotoxicity is the main effec-
tor mechanism by which NK cells control virus infection through activation receptors.
Complemented by in vitro assays, we delineated the requirements for NK cell cytotoxicity
and identified a 2-step mechanism for NK-mediated cytotoxicity. Firstly, NK cells require
cytokine signals for the accumulation of cytotolytic proteins. Secondly, direct target cell
recognition results in release of the cytolytic cargo and lysis of virus-infected cells. Our
study demonstrates the integration of NK activation and cytokine receptor signals are
required for effective viral control.
Introduction
Natural killer (NK) cells are a critical component of the innate immune system. They play
essential roles in controlling viral infections as illustrated in patients with selective NK cell
defects who are susceptible to recurrent herpesvirus infections [1]. These clinical responses are
recapitulated in animal studies, particularly with murine cytomegalovirus (MCMV), a natural
mouse pathogen of the β-herpesvirus family, thus allowing further mechanistic insight. In the
C57BL/6 (B6) mouse strain, NK cell-mediated control of MCMV infection is dependent upon
the Ly49H activation receptor which is responsible for genetic resistance and is absent in sus-
ceptible strains such as BALB/c [2–4]. Ly49H specifically recognizes the MCMV-encoded
ligand, m157, triggering NK cell activation and subsequent control of MCMV [5, 6]. Ly49H
associates with the DAP12 adaptor molecule required for Ly49H surface expression and signal-
ing. DAP12 has cytoplasmic immunoreceptor tyrosine-based activation motifs (ITAM) and
directly mediates Ly49H signaling [5–7]. While the requirement of the related adapter mole-
cule DAP10 is controversial [8, 9], Ly49H-dependent antiviral control is also illustrated by
selection pressure in T cell-deficient hosts in which escape viral clones deficient in m157
expression emerge after several weeks following infection [10]. Unlike with the wild-type (WT)
virus, these escape MCMV clones cannot be controlled by NK cells, even in Ly49H-sufficient
mouse strains [10, 11]. Recently, infection with multiple, purified wild isolates of MCMV con-
firmed that Ly49H+ NK cells could only control m157-sufficient virus, resulting in an apparent
outgrowth of m157-deficient strains [12]. Thus, Ly49H-m157 interactions are critical for
MCMV control.
As with other NK cell activation receptors, Ly49H recognition of m157 in vitro can trigger
two major effector functions: target-cell lysis (cytotoxicity) and cytokine production [5, 13].
Indeed, NK cell activation receptor ligands expressed on insect cells are sufficient to trigger NK
cell degranulation as measured by cell-surface CD107a (LAMP1) staining [14]. Stimulation of
NK cells with plate-bound anti-activation receptor antibodies, such as anti-Ly49H, causes simi-
lar NK cell activation and target killing [13, 15]. In addition, Ly49H-dependent stimulation in
vitro leads to release of the signature NK cell cytokine, interferon gamma (IFNγ) [5], which has
direct antiviral activity and can modulate subsequent immune responses [16, 17]. Indeed, prior
to identification of the role of Ly49H, NK cell-dependent control of MCMV in B6 mice was
reported to be dependent on both cytotoxicity and IFNγ [18, 19]. A more recent report also
supports a role for IFNγ in NK cell control of MCMV but cytotoxicity was not examined [20].
Moreover, NK cells also release chemokines upon Ly49H stimulation [21]. Thus, it is still
unclear which NK cell effector mechanisms, i.e. cytotoxicity versus cytokine/chemokine pro-
duction, contribute specifically to Ly49H-dependent clearance of MCMV.
Cytokines in Ly49H-Dependent MCMV Control
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In addition to stimulation through their activation receptors, NK cells can be non-specifi-
cally activated through cytokine receptors to produce other cytokines [22–24]. During MCMV
infections, other immune and non-immune cells produce an array of pro-inflammatory cyto-
kines including IFNα/β [25] (IFN-I), IL-12 and IL-18 [26]. Many of these cytokines are
induced by pattern receptors, such as TLRs, which are required for MCMV control, even in
Ly49H-sufficient mice [27]. Importantly, these cytokines can directly or indirectly stimulate
NK cells to produce IFNγ and this early production of IFNγ by NK cells can influence antiviral
responses. However, the pleiotropic nature of the antiviral cytokines, such as IFN-I, IL-12, and
IL-18, makes it difficult to dissect their broader effects on viral replication from their role in
stimulating NK cell cytokine production [16].
Indeed, several cytokines are also capable of potentiating NK cell cytotoxic function [24].
Pretreatment of mice with poly(I:C) enhances both in vivo and ex vivo cytotoxic responses
against various NK cell targets [28]. This effect is due to indirect stimulation of NK cells via
accessory cells responding to poly(I:C) through the nucleic acid sensors, subsequently inducing
the production of IL-12 and IFN-I [29]. These cytokines also induce DCs to produce IL-15,
which has been linked to “priming” of NK cells thereby enhancing killing of target cells as well
as increasing production of IFNγ and granzyme B (GzmB) [30]. In addition, resting murine
NK cells express abundant transcripts for their cytotoxic proteins; cytokines such as IL-2 and
IL-15 induce production of GzmB and perforin protein, which also correlates with increased
target cell lysis [31]. It has been postulated that the elevated protein levels of these effector mol-
ecules facilitate NK cytotoxicity mediated through activation receptors, such as Ly49H, but
direct evidence is not available and the roles of other cytokines have not been explored.
Therefore, it has been challenging to determine the precise NK cell effector mechanism
mediated by Ly49H-dependent activation of NK cells in controlling MCMV as well as the role
of non-specific cytokine stimulation of NK cells in this control. Herein we employed an in vivo
viral competition approach which, together with in vitro and other in vivo studies, strongly sug-
gests that NK cells require triggering of the Ly49H activation receptor for degranulation and
that certain cytokine signals are also required to promote sufficient GzmB protein levels for
effective cytotoxic elimination of MCMV.
Results
Characterization of global immune defects on splenic MCMV titers
To address the relative impact of NK cells and Ly49H versus cytokine signaling on MCMV
infection, we evaluated the splenic titers of mice three days after challenge with a low dose
(5000 PFU) of a wild type (WT) MCMV clone (Fig 1A). Importantly, our studies allowed a
direct comparison of different genetically deficient mice on the C57BL/6 (B6) background. We
found the expected marked susceptibility in B6 mice depleted of NK1.1-expressing cells or that
were genetically deficient in Ly49H expression (B6.BxD8 strain). Compared to B6 mice, we
also noted either no effect of IL-12 cytokine deficiency (p40 subunit) or relatively minor effects
of IL-12Rβ2 (three-fold) and IFNγ (two-fold) deficiency on titers. Moreover, interferon α/β
receptor 1 deficiency (IFNAR1-/-) increased titers over 30-fold but not to the levels seen with
NK cell or Ly49H deficiency. The loss of perforin (Prf1-/-) resulted in elevated viral titers simi-
lar to both Ly49H and NK cell deficiency, suggesting that cytotoxic effector function is a key
mechanism in early splenic control of MCMV, but the role of cytotoxic T cells could not be
excluded. On the other hand, when we challenged a cohort of mice for five days with a larger
dose (20000 PFU) of MCMV, we observed somewhat different effects (Fig 1B). While we again
observed the expected susceptibility in mice depleted of NK1.1-expressing cells and also a
minor effect of IL-12Rβ2 and IFNγ deficiency, IFNAR1-/- mice demonstrated markedly
Cytokines in Ly49H-Dependent MCMV Control
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increased titers (over 1000-fold) approaching levels seen with NK cell depletion (Fig 1B). Thus,
overall viral titers suggest dominant roles for perforin and IFN-I in control of MCMV with
Fig 1. NK cells specifically control MCMV infection via cytotoxic effector molecules. (A) Splenic viral titers were analyzed by qPCR following a three-
day infection with WTMCMV (5000 PFU/mouse) or (B) five-day infection with WTMCMV (20000 PFU/mouse). Statistical analysis performed by comparing
values fromWTmice with genetically modified or antibody-treated mice. (C) Schematic of the dual-infection system depicting the starting viral mixture and
two possible results: Ly49H-dependent control of WTMCMVwith resulting selection of Δm157 clones vs. equivalent replication of both MCMV strains due to
absence of Ly49H-dependent control of WTMCMV. (D) Splenic viral titers following a five-day infection, as in (B), with the indicated dose and strains
following antibody treatment. (E-F) Splenic viral escape (Δm157) frequency determined five days after a mixed MCMV infection with WTMCMV and Δm157
(20000 PFU/mouse). NK1.1 antibody was administered where indicated 48hrs prior to infection. Data are combined from two independent experiments with
individual points representing a single mouse. L = Limit of quantification. I = Input frequency (10% frequency of Δm157). ****p < .0001, ***p < .001,
**p < .01, *p < .05, ns = not significant.
doi:10.1371/journal.ppat.1005323.g001
Cytokines in Ly49H-Dependent MCMV Control
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contributions from IL-12 and IFNγ, but their relationship to Ly49H-dependent responses
remained unclear as their effects can be dependent on the viral dose.
In vivo viral competition assay to determine Ly49H-dependent NK cell
activity against MCMV
Since it was challenging to attribute functional defects specifically to NK cells and Ly49H when
genetically deficient mice were infected with WTMCMV and viral titers or survival were
assessed, we designed and validated an in vivo dual-infection, viral competition assay. To spe-
cifically determine the role of Ly49H-dependent and independent control of MCMV in vivo,
we inoculated mice with a mixture of MCMV lacking m157 expression (Δm157) due to a single
point mutation, and WTMCMV at a defined frequency. We hypothesized that Ly49H-depen-
dent control of WTMCMV should result in a proportional increase in Δm157 virions, as mea-
sured by the splenic frequency of Δm157 relative to WTMCMV (Fig 1C). By contrast, absence
of Ly49H-dependent control should not lead to selection of Δm157.
To validate this approach, we first studied B6 mice individually infected with WTMCMV
or Δm157 and treated with either isotype control antibody or anti-NK1.1 (Fig 1D). The dose of
viral inoculum was chosen to reflect the frequencies to be used in the dual-infection assay (Fig
1C). We found that depletion of NK cells led to markedly elevated WTMCMV levels with no
additional effect on Δm157 titers which were already elevated in control antibody-treated mice
despite a lower inoculum (Fig 1D). We next characterized the splenic frequency of Δm157
virus in NK cell-depleted and control mice after inoculation with a mixture of 90%WT
MCMV and 10% Δm157 viruses (Fig 1E). Indeed, in B6 mice treated with the control antibody,
the Δm157 viral frequency increased from input level (10%) to the limit of the assay (75%),
indicating selective outgrowth of Δm157. However, in mice depleted of NK cells, the Δm157
MCMV frequency was similar to the input inoculum (Fig 1E), even though overall viral titers
were significantly elevated (S1A Fig). These results demonstrate that without the selective pres-
sure contributed by NK cells, both WT and m157-deficient viruses replicate to similar levels in
vivo.
The degree of viral burden might contribute to differences in the ability of NK cells to clear
WTMCMV during the viral competition assay. Consistent with this, we have seen that splenic
selection of Δm157 in B6 mice can be overwhelmed with a larger viral inoculum (S1B and S1C
Fig). However, 1e6 PFU per mouse (50-fold higher than in the experiments performed within
the rest of this study) were required to observe such an effect. Therefore, we utilized a low inoc-
ulum (2e4 PFU per mouse) that allowed for optimal discrimination of Ly49H-dependent clear-
ance without overwhelming NK cell-dependent viral control.
When we infected the Ly49H-deficient B6.BxD8 strain, we observed no Δm157 selection,
demonstrating that the co-infection reflected Ly49H-dependent antiviral function (Fig 1F).
There was also impaired Δm157 selection in DAP12–/–and DAP10–/–DAP12–/–mice. As genetic
deficiency of DAP12 prevents surface expression of Ly49H, we also analyzed DAP12 knock-in
(KI) mice having a mutation in the ITAM that allows normal Ly49H surface expression with
defective signaling [7]. The DAP12 KI mice also showed no selection. Although DAP10 can
associate with Ly49H, the single DAP10–/–animals allowed Δm157 to accumulate, indicating
that DAP10 is not required as previously reported [9] while contrasting with other reports [8].
Consistent with previous data (Figs 1E and S1A), viral titers were elevated in all dual-infected
mice in which selection was impaired (S1D Fig). Thus, Ly49H and DAP12 are required for
Δm157 selection, consistent with previous studies on Ly49H-DAP12-dependent mechanism
for WTMCMV control [5, 7] and emergence of Δm157 in T cell-deficient mice [10].
Cytokines in Ly49H-Dependent MCMV Control
PLOS Pathogens | DOI:10.1371/journal.ppat.1005323 December 31, 2015 5 / 24
Δm157 selection is preserved during individual deficiencies affecting
innate immunity
When inoculated with a mixed MCMV inoculum, mice with TLR signaling deficiency due to
absence of both TLR signaling adapters (myeloid differentiation factor 88, MyD88; and Toll/
IL-1R domain-containing adapter inducing IFN-β, TRIF) demonstrated enhanced susceptibil-
ity (Fig 2A). Though consistent with prior reports demonstrating that TLR deficiency leads to
enhanced susceptibility to MCMV [27], MyD88–/–TRIF–/–mice showed no defect in Δm157
Fig 2. NK cell cytotoxic control of MCMV requires both IL-12 and IFN-I signaling. (A) Splenic viral titers
and (B-F) escape (Δm157) frequency determined five days after a mixed MCMV infection (20000 PFU/
mouse), as in Fig 1. (D) Anti-IFNAR1 antibody (or isotype control) was administered where indicated 24hrs
prior to infection. Data are combined from two to three independent experiments with individual points
representing a single mouse. L = Limit of quantification. I = Input frequency (10%).
doi:10.1371/journal.ppat.1005323.g002
Cytokines in Ly49H-Dependent MCMV Control
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selection (Fig 2B), suggesting that the TLR signaling-dependent results were not due to effects
on Ly49H-dependent control. Similarly, we observed that deficiency of IFNAR1 markedly
affected infection with a mixed MCMV inoculum (Fig 2A) but did not markedly affect Δm157
selection (Fig 2B). Notably, in both cases, there was Δm157 selection even though overall viral
titers were elevated in the absence of TLR or IFN-I responses (Fig 2A), indicating that the viral
competition assay could reveal Ly49H-dependent effects even during marked viremia.
We next assessed the role of two other cytokines, IL-18 and IL-12, previously demonstrated
to enhance NK cell function both in vivo and in vitro [32]. However, deficiency of IL-18 or IL-
12p40 also did not result in loss of viral selection (Fig 2C). Furthermore, Batf3-dependent con-
ventional DC subsets that present IL-15 to NK cells were also not required to control WT
MCMV (Fig 2C). Consistent with the lack of Δm157 outgrowth, viral titers were also similar to
B6 mice (S1E Fig). Taken together, these findings demonstrate that Δm157 selection remains
intact in the face of individual deficiencies of TLR signaling, IFN-I, IL-18, or IL-12, as well as
Batf3 deficiency. Since overall viral titers were higher in the absence of TLR signaling and
IFN-I deficiency, our findings suggest that Ly49H-dependent control of WTMCMV could
occur normally despite global deficits of innate antiviral immunity which affect Ly49H-inde-
pendent control of both WTMCMV and Δm157.
Δm157 selection is impaired in the absence of both IFN-I and IL-12
signaling
Since we found no major effect on Δm157 selection in mice with single immune deficiencies,
we next assessed their potential redundant roles with IFN-I. The combination of anti-IFNAR1
blockade with MyD88 deficiency markedly impaired Δm157 selection (Fig 2D). Notably, this
loss of selection was not seen in B6 mice treated with anti-IFNAR1 or MyD88–/–mice treated
with an isotype control, indicating that both MyD88-dependent and IFN I-dependent path-
ways are critical for Δm157 selection by Ly49H+ NK cells. Since MyD88–/–mice fail to elaborate
both IL-12 [27] and IL-18 [33], we next combined IFNAR1 blockade with IL-12 or IL-18 defi-
ciency. While IFNAR1 blockade in IL-18–/–mice had no effect on Δm157 selection, IFNAR1
blockade plus either IL-12p40 or IL-12Rβ2 deficiency led to impaired selection, similar to
IFNAR1 blockade in MyD88-deficient mice (Fig 2D). To further substantiate these findings,
we assessed IFNAR1–/–mice genetically deficient in either IL-12 cytokine or receptor (Fig 2E).
Both of these compound cytokine genetic deficiencies compromised Δm157 selection and
resulted in elevated viral titers (S1F Fig). Taken together, these findings support a redundant
relationship between IL-12 and IFN-I in promoting Ly49H-dependent control of WTMCMV.
Δm157 selection in the spleen is dependent upon cytotoxic
degranulation but not IFNγ
To better understand how IL-12 and IFN-I affect Ly49H+ NK cell activities, we studied the
classical NK cell effector functions, cytotoxicity and IFNγ production. Perforin was critical for
promoting Δm157 selection (Fig 2F). Similarly, Jinx [34] and Lyst [35] mice, both of which
have distinct defects in cytotoxicity, recapitulated the impaired Δm157 selection observed in
Prf1–/–mice. Surprisingly, however, Δm157 selection was observed in IFNγ-/- and IFNγR-/-
mice; both were similar to B6. Viral titers supported our observations in these strains (S1G
Fig). However, a prior publication has demonstrated that cytotoxic control of MCMV during
acute infection occurs primarily within the spleen and IFNγ-dependent control is more promi-
nent in the liver [19] while a more recent study suggests IFNγ affects both spleen and liver con-
trol [18]. To address whether IFNγ contributes to m157-dependent control in the liver, we
evaluated the consequences of hepatic MCMV selection in B6, IFNγ-/-, and Prf1-/- mice (S1H
Cytokines in Ly49H-Dependent MCMV Control
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Fig). We found that Δm157 selection in the liver was incomplete in the B6 background, con-
firming that Ly49H-dependent mechanisms are not as prominent in the liver compared to the
spleen. As observed in the spleen (Fig 2F), Prf1-/- mice were not able to select for Δm157 in the
liver (S1H Fig), demonstrating that the primary mechanism responsible for selection in these
organs requires perforin-mediated cytotoxicity. We observed only partial hepatic Δm157 selec-
tion in IFNγ-/- mice, suggesting that in contrast to the spleen, IFNγ exerts a mild influence on
MCMV control in the liver. The hepatic titers were mildly elevated (about 10-fold) in the
IFNγ-/- strain and markedly higher (1000-fold) in Prf1-/- mice when compared to B6 mice (S1I
Fig), similar with what we observed in the spleen (S1G Fig). In summary, these results suggest
that Ly49H-dependent control of WTMCMV in the spleen and liver depends on perforin-
mediated cytotoxicity and IFNγ partially contributes to Δm157 selection in the liver.
Signaling through Ly49H alone stimulates degranulation
To further evaluate the role of IL-12 and IFN-I in Ly49H-dependent MCMV control, we per-
formed in vitro assays. As cytotoxicity is required for Ly49H-dependent MCMV control, we
first studied NK cell degranulation. NK cells did not degranulate in response to cytokines alone
(Fig 3A). Instead, stimulation with transgenic m157-expressing (m157-Tg) splenocytes [36]
but not WT splenocytes induced degranulation in Ly49H+ cells. Almost all NK cells that
expressed lower levels of cell-surface Ly49H (Ly49Hdim) were CD107a+, suggesting that virtu-
ally all Ly49H+ NK cells that encountered m157 during the course of the experiment subse-
quently degranulated. The CD107a-specific response to m157-Tg stimulators was abrogated in
Jinx and B6.BxD8 mice, confirming that Ly49H-signaling specifically induced degranulation
(Fig 3B). Jinx NK cells displayed the Ly49Hdim population after m157-Tg exposure, indicating
that these NK cells were indeed triggered but did not degranulate. Stimulation of DAP12-defi-
cient NK cells did not induce any specific degranulation whereas stimulation of DAP10-defi-
cient NK cells resulted in degranulation similar to WT controls (Fig 3C), indicating that
DAP12, but not DAP10 is involved in Ly49H-mediated degranulation and consistent with our
in vivo data on Δm157 selection (Fig 1F). Interestingly, m157-Tg stimulation did not induce
the Ly49Hdim population in DAP12-deficient NK cells, indicating that signaling through
Ly49H and DAP12 is required for the emergence of this population. These data also show that
DAP12 is cell-intrinsically required on NK cells, which was also confirmed by co-culture of
purified NK cells with m157-Tg murine embryonic fibroblasts (MEF) (Fig 3D). Finally, com-
bining m157-Tg stimulation with cytokines did not further enhance the percentage or MFI of
the CD107a+ NK cells (Fig 3A–3D). Together, these in vitro data show that activation receptor
engagement by ligand alone is sufficient for degranulation, and suggest that IL-12 and IFN-I
play another role to enhance NK cell cytotoxicity.
Signaling through cytokine receptor is solely required for GzmB
production in NK cells
Since control of MCMV via cytotoxic NK cell effector function is critically dependent upon the
pro-apoptotic activity of GzmB following degranulation [31], and we demonstrated that
degranulation, per se, was not influenced by IFN-I or IL-12, we next assessed the ability of
these cytokines to affect GzmB protein expression. Indeed, addition of either IFNβ or IL-12 to
NK cells in vitro induced GzmB production, without affecting Ly49H levels (Fig 4A). The
increase in GzmBMFI likely corresponds to increased protein levels of GzmB rather than a
conformational change in GzmB such that it is more readily detectable as the NK cells show
more cytotoxic function. However, it cannot be distinguished if the increased GzmBMFI
reflects greater GzmB content per granule, greater number of GzmB+ granules, or a
Cytokines in Ly49H-Dependent MCMV Control
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Fig 3. In vitro stimulation of NK cells with m157-Tg splenocytes alone induces DAP12-dependent degranulation. (A-C) Splenocytes from CD45.2 WT
or indicated strain were mixed with CD45.1/2 congenic m157-Tg or WT splenocytes at a 1:1 ratio in the presence of the indicated cytokines. IFNβwas used
at 100–200 U/ml, IL-12 was used at 10–20 ng/ml. NK cell degranulation was measured after a 6–9 hr incubation. (A) Representative FACS plots are shown
on the left and percentage of CD107a+ cells within the Ly49H+ NK cell population of biological duplicates is shown on the right. (B) Jinx or B6.BxD8
splenocytes were mixed with m157-Tg or control splenocytes. For experiments with B6.BxD8 percentage of CD107a+ NK cells is calculated over the whole
NK cell population. (C) DAP10-/- or DAP12 KI splenocytes were mixed with adapter-expressing m157-Tg or control splenocytes. (D) Purified NK cells were
cultured with m157-Tg or WT control murine embryonic fibroblasts (MEF) and analyzed as in (A). Data are representative of at least two independent
experiments.
doi:10.1371/journal.ppat.1005323.g003
Cytokines in Ly49H-Dependent MCMV Control
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Fig 4. In vitro stimulation of NK cells with IFN-I and IL-12 induces GzmB expression in a cell-intrinsic manner. (A-D) Splenocytes from CD45.2WT or
indicated strain were mixed with CD45.1/2 congenic m157-Tg or WT splenocytes in the presence of the indicated cytokines. IFNβwas used at 100–200 U/ml,
IL-12 was used at 10–20 ng/ml, unless otherwise indicated. NK cell GzmB was measured after 16–20 hr incubation. (A) Representative FACS plots are
shown on the left and MFI of GzmB in NK cell population of biological duplicates is shown on the right. (B and C) Splenocytes were incubated with the
indicated cytokine without stimulator splenocytes. (C) The concentration of the cytokines used were IFNα4 (200 U/ml), IFNβ (200 U/ml), IL-12 (20 ng/ml), IL-2
(200 U/ml), IL-6 (20 ng/ml), IL-15 (20 ng/ml), IL-18 (20 ng/ml). (D) IL-12Rβ2-/- or IFNAR1-/- splenocytes were mixed with cytokine receptor sufficient m157-Tg
or control splenocytes. MFI = median fluorescence intensity. (E) Purified NK cells were cultured with m157-Tg or WT control MEF and analyzed as in (A).
Data are representative of at least two independent experiments.
doi:10.1371/journal.ppat.1005323.g004
Cytokines in Ly49H-Dependent MCMV Control
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combination of both. IFNβ was more potent than IL-12 in inducing GzmB. Signaling
through Ly49H itself with m157-Tg targets did not induce GzmB and did not substantially
enhance GzmB levels induced by cytokines. Stimulation of GzmB production by cytokines is
consistent with prior studies [31], but the role of IFN-I had not been extensively evaluated.
Since IFNα and IFNβ could differentially affect GzmB production, we compared them
directly. Both IFN-I subtypes induced GzmB in a dose-dependent fashion, but IFNβ was >30
times more potent in inducing GzmB than IFNα4 (Fig 4B). Simultaneous addition of IFNβ
and IL-12 resulted in a synergistic effect on GzmB production and reached levels similar to
those induced by IL-2 and IL-15 (Fig 4C). To determine if the requirements for IFNAR1 or
IL-12Rβ2 were NK cell-intrinsic for GzmB production, splenocytes deficient in either of
these receptors were stimulated with cytokine and WT stimulator cells. In terms of GzmB
protein production, NK cells deficient in IL-12Rβ2 did not respond to IL-12, but still
responded to IFNβ whereas IFNAR1-/- NK cells did not respond to IFNβ, but responded to
IL-12 (Fig 4D). This NK cell-intrinsic response was confirmed by stimulating purified NK
cells with MEFs and IFNβ or IL-12 (Fig 4E). Intriguingly, the IFNβ-induced GzmB accumu-
lation was greater in the Ly49H+ compared to the Ly49H- NK cells, whereas in response to
IL-12, GzmB accumulation was more pronounced in the presence of m157 (S2A Fig). Taken
together, these data suggest that both Ly49H and either IFNβ or IL-12 are intrinsically neces-
sary for efficient cytotoxicity in vivo.
IFN-I and IL-12 are redundantly required for effective granzyme B and
perforin accumulation in NK cells
Interestingly, at three days following MCMV infection, we found that levels of GzmB and Prf1
in splenic NK cells examined ex vivo were significantly elevated in mice with deficiency in
either IFNAR1 or IL-12p40 (Fig 5A and 5B). Upregulation of GzmB appeared to be equivalent
in both Ly49H+ and Ly49H- cells and did not require the presence of m157-expressing virus at
40 hours after infection (Fig 5C). IFNAR1–/–mice demonstrated a less robust increase in the
expression of GzmB, as compared to WT and IL-12p40-deficient mice which displayed equiva-
lent levels. Prf1 production was increased in IFNAR1–/–mice while IL-12p40–/–mice displayed
decreased levels of Prf1 compared to WT, suggesting that GzmB and Prf1 are differentially reg-
ulated. Importantly, double cytokine-deficient mice did not display enhanced GzmB nor Prf1
protein levels following infection (Fig 5A and 5B). Indeed, the GzmB levels were even below
those observed in uninfected WTmice, suggesting that both IL-12 and IFN-I contribute to pro-
duction of small amounts of GzmB in naïve mice. For Prf1 this effect was not clearly observ-
able, which may be due to the less robust Prf1 changes or detection. WTMCMV induced
elevated levels of GzmB in Ly49H+ NK cells compared to their Ly49H- counterparts, similar to
what was observed in vitro (S2 Fig). Importantly, this effect was also observed for Δm157
MCMV (S2B Fig), further indicating that signaling through Ly49H is not required for
enhanced GzmB production in Ly49H+ NK cells during MCMV infection. Regardless, both IL-
12 and IFN-I redundantly contribute to enhanced GzmB and Prf1 protein expression during
MCMV infection.
To confirm that NK cell-intrinsic signaling by cytokines was required, we adoptively trans-
ferred WT or IFNAR1-/-xIL-12Rβ2-/- splenocytes into congenic WT hosts that were simulta-
neously infected with MCMV. We observed no increase in GzmB levels in the double-deficient
donor NK cells whereas WT donor control and WT host control NK cells produced the
expected increased levels of GzmB (Fig 5D). These results indicate that the enhancement of
GzmB protein expression by IFN-I or IL-12 signaling is NK cell-intrinsic during MCMV-
infection.
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IFN-I signaling is required for optimal Ly49H-dependent cytotoxicity in
vivo
To directly determine the requirement for both Ly49H and IFN-I activation for cytotoxicity in
vivo, we determined the in vivo cytotoxic elimination of m157-expressing cells (Fig 6A). Fol-
lowing injection of equal numbers of congenic m157-Tg and WT splenocytes differentially
labeled with CFSE into control-treated mice, we found there were low levels (15–35%) of
m157-specific elimination (Fig 6A and 6B), consistent with previous findings on m157-specific
rejection under steady-state conditions [37, 38]. Anti-NK1.1 depletion abrogated m157-spe-
cific elimination of target cells, confirming NK cell dependence. However, mice pretreated with
poly(I:C) exhibited 3-fold higher levels of m157-specific rejection as compared to control-
Fig 5. IFN-I or IL-12 are required for GzmB and Prf1 induction in NK cells in a cell intrinsic manner during MCMV infection. (A and B) Mice deficient in
IFNAR1 and/or IL-12p40 were infected with WTMCMV at 5000 PFU/mouse. After 3 days, splenocytes were harvested and analyzed for GzmB and Prf1
expression as indicated. Representative contour plots of individual mice are shown in (A). The median fluorescence intensity (MFI) is indicated for each plot
and the cumulative data for one experiment is shown in (B). (C) GzmB levels of WTmice infected with 1x105 PFUWT or Δm157 MCMV 2 days after infection.
(D) 40x106 WT or IFNAR1-/-xIL-12Rβ2-/- splenocytes were adoptively transferred to congenic host that was simultaneously infected with 1x105 PFUMCMV/
mouse. GzmB levels 2 days post-infection in host and transferred NK cells is depicted. Data are representative of three to four independent experiments with
individual points representing a single mouse.
doi:10.1371/journal.ppat.1005323.g005
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treated mice (Fig 6A and 6B). Blockade of Ly49H prevented m157-expressing target elimina-
tion in poly(I:C)-treated mice, confirming the role of Ly49H (Fig 6C). Similar results were
Fig 6. m157-specific cytotoxicity in vivo is greatly enhanced by poly(I:C) and dependent on IFN-I and
degranulation. (A-D) Mice were i.p. injected with 100 μg poly(I:C), PBS, 200 μg anti-NK1.1, 200 μg anti-
Ly49H and/or isotype control. After 16 hours 2x106 differentially CFSE-labeled splenocytes were injected
intravenously. Three hours after adoptive transfer splenocytes were analyzed by flow cytometry. (A)
Representative histograms showing splenic CD19+CFSE+ cells. Numbers indicate percentage of m157-Tg
CFSElow andWT CFSEhigh cells. (B-D) Specific lysis of m157-Tg targets. (E) Mice were injected IP with 100
ug poly(I:C) or PBS. After 16 hours the spleens were harvested and NK cells were analyzed for GzmB. Data
are representative of two to three independent experiments with individual points representing a single
mouse.
doi:10.1371/journal.ppat.1005323.g006
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obtained in B6.BxD8 mice specifically lacking the Ly49H receptor. Specific elimination was
also abrogated in Jinx mice (Fig 6D), indicating that m157-expressing target elimination in
vivo in poly(I:C)-treated mice is due to cytotoxicity. The m157-specific killing was 3-fold lower
in IFNAR1-/- mice treated with poly(I:C) as compared to WT control mice, showing IFN-I sig-
naling affects m157-specific rejection (Fig 6D). This defective cytotoxic capacity in IFNAR1-/-
mice correlated with a lack of increased GzmB production in response to poly(I:C) (Fig 6E).
Conversely, Jinx mice failed to eliminate m157-expressing targets (Fig 6D) even though GzmB
levels were similar to WT mice (Fig 6E), highlighting the requirement of both degranulation
and cytokine activation for optimal Ly49H-dependent cytotoxicity in vivo.
m157-specific cytotoxicity during MCMV infection in vivo depends on IL-
12 and IFN-I
To directly assess the role of cytotoxicity during MCMV infections, we performed rejection
assays in infected mice. During the first day post-infection, in vivo cytotoxicity of m157-Tg tar-
gets was similar to untreated controls while it increased on day 2 and plateaued at days 3 and 4
(Fig 7A). At day 2 after infection, GzmB and perforin responses in the NK cells peaked (S3A
Fig and [31]), but the cytotoxic capacity was only modestly but not significantly increased.
However, at this time the number of detectable NK cells in the spleen dramatically drops to
approximately 30% of steady-state levels [39], which may explain the discrepancy of enhanced
GzmB and perforin production in NK cells with only modestly increased in vivo cytotoxic
capacity. At day 3–4 after infection, GzmB levels decreased (S3A Fig) but the number of detect-
able NK cells increased and the net result was more potent m157-specific target clearance.
Despite a requirement for m157 expression on the target, there was otherwise no overt role for
m157 in potentiating NK cell cytotoxicity during MCMV infection, as m157-specific rejection
of targets was similar at day 3 in mice infected with Δm157 or WTMCMV (Fig 7B). These
data show that NK cell cytotoxicity increases during the first days after MCMV and plateaus at
day 3, which reflects the capacity of NK cell mediated control of MCMV during this time.
Fig 7. IL-12 or IFN-I are required for m157-specfic cytotoxicity in vivo during MCMV infection.Mice
were i.p. injected with MCMV (10000 PFU/mouse) and at the indicated timepoint after infection an in vivo
cytotoxicity assay was performed as in Fig 6. (A)m157-specific rejection was analyzed at days 1–4 after
MCMV infection. (B)Mice were infected with WT or Δm157 MCMV for 3 days, after which m157-specific
rejection was analyzed. (C)m157-specific rejection was measured in mice deficient in IFNAR1, IL-12Rβ2, or
both was analyzed at 3 days post-infection. Data are representative of three to four independent experiments
with individual points representing a single mouse.
doi:10.1371/journal.ppat.1005323.g007
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Finally, we found mice deficient in IFNAR1 were substantially hampered in their cytolytic
capacity during MCMV infection (Fig 7C). These mice showed a 40% reduction in m157-spe-
cific killing, but the remaining cytotoxic capacity was still sufficient for Δm157 selection,
though somewhat incomplete (Fig 2B). Interestingly, IL-12 alone played no detectable role in
cytotoxicity in vivo as IL-12Rβ2-/- mice showed similar levels of m157-specific rejection. How-
ever in mice deficient in both IFNAR1 and IL-12Rβ2, m157-specific killing was reduced to
below baseline WT levels (Fig 7C). Moreover, uninfected IFNAR1-/-xIL-12Rβ2-/- mice showed
reduced baseline m157-specific target rejection despite normal maturation and functional
capacity of the IFNAR1-/-xIL-12Rβ2-/- NK cells (S3B–S3E Fig), showing a role for cytokine
activation even under steady-state conditions. Together, these results closely mirror the results
on m157-dependent MCMV selection as well as GzmB production (Figs 2E, 3A and 4A), indi-
cating that both IFN-I and IL-12 contribute to NK cell cytotoxicity during MCMV infections.
Discussion
Herein we used an in vivo viral competition assay to specifically demonstrate that Ly49H-
mediated MCMV control is predominately due to cytotoxicity that is enhanced by cytokine sig-
naling, independent of IFNγ. All strains of mice tested here with defects in cytotoxicity, includ-
ing granule formation (Lyst), exocytosis (Jinx), or perforin, showed the same effect, i.e., an
inability of Ly49H+ NK cells to control MCMV, as evidenced by an absence of Δm157 MCMV
selection. Our findings are independent of overall viral titers, providing unequivocal evidence
for cytotoxicity despite potential confounding effects.
A recent report described that both Ly49H-m157 engagement and IFNγ production were
important in NK-mediated control of MCMV [20]. Interestingly, mortality did not correlate
well with splenic titers in prior studies that have examined mice globally deficient in IFNγ, sug-
gesting that the cytokine likely potentiates other critical aspects of the innate immune response.
For example, Fodil et al demonstrated a marked effect on survival with only a mild (1-log)
increase in splenic titers of WTMCMV if Ly49H was transgenically expressed in a mouse
strain deficient for IFNγ production [20]. We have confirmed these overall WT MCMV titer
differences in our studies within both the splenic and hepatic compartments of IFNγ-/- mice.
However, our data suggest that global defects can affect Ly49H-independent viral control, sug-
gesting that the role of IFNγ in antiviral control by Ly49H+ NK cells can be difficult to resolve
when studying mice globally lacking immune molecules and assessing overall viral titers [18,
19].
Interestingly, Ly49H-dependent degranulation occurred in naïve mouse NK cells in vitro,
reminiscent of activation receptor-induced granule exocytosis of human NK cells in an LFA-
1-dependent manner in an in vitro system that limited the number of receptor and ligand
pairs. The combination of engagement of Fc receptor and LFA-1 by ICAM on insect cells facili-
tated human NK cell degranulation [14] and triggering of multiple activation receptors was
shown to further increase human NK cell degranulation [40]. Of note is that our in vitro assays
utilized syngeneic splenocytes as stimulators differing from control splenocytes only in the
transgenic expression of m157. The stimulator cells therefore expressed the steady state reper-
toire of the relevant adhesion molecules as well as activation and inhibitory ligands, which
together contributed to degranulation. Nonetheless, our studies indicate that degranulation
was insufficient for effective target killing and provide a cautionary note that assessment of
degranulation by CD107a may not be a good correlate for cytotoxicity under certain
conditions.
Our studies indicate that effective NK cell cytotoxicity requires other signals, in addition to
Ly49H triggering. The in vivo viral competition assay demonstrated a requirement for either
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IL-12 or IFN-I acting directly on NK cells to promote activation receptor-mediated killing of
MCMV-infected cells. In the presence of either IL-12 or IFN-I alone, Ly49H-dependent con-
trol appeared to occur, despite overall increases in viral titers, likely due to the pleiotropic
effects of these cytokines on the immune response. Interestingly, the effect of IFN-I was much
greater than that of IL-12, but it was only when both were genetically absent and/or neutral-
ized, that Ly49H-dependent control was markedly affected, as shown by significant effects on
Δm157 MCMV selection. Regardless, both cytokines can independently contribute to Ly49H-
mediated cytotoxicity via a mechanism involving upregulation of GzmB protein expression,
markedly expanding prior observations that IL-15 can also induce this effect [30, 31].
Our results showing an important role for IFN-I and IL-12 on Ly49H-dependent viral con-
trol was unexpected as IL-15 is a potent stimulator of GzmB protein production and IL-15 is
produced during MCMV infections [31, 41]. Prior studies suggested a role for cross-presenta-
tion of IL-15 by dendritic cells as a critical component in NK cell responses during viral infec-
tions [30]. In the current study, we did not examine the role of IL-15 because mice lacking IL-
15 or any component of the IL-15 receptor lack NK cells [42]. However, here we indirectly
addressed the role of IL-15 priming of NK cells by DCs by utilizing Batf3-deficient mice [43]
that fail to develop CD8α DC subsets. We observed that Batf3-dependent DCs were not
required for the Ly49H-dependent cytotoxicity observed during MCMV infection. Although
IL-15 should act directly on NK cells and is thought to be downstream of IL-12 and IFN-I stim-
ulation of DCs, we found that the IL-12 and IFN-I effects studied here were due to direct effects
of these cytokines on the NK cells themselves. Therefore, our current studies showed that IL-12
and IFN-I had profound effects directly on NK cells, suggesting that IL-15 could account for
the residual IL-12- and IFN-I-independent effects on Ly49H-mediated MCMV control, or that
IL-15 acts together with IL-12 and IFN-I in a more complex manner.
Our findings here also markedly extend prior studies on the role of both IFN-I and IL-12 in
affecting NK cell responses during MCMV infection. Recently, both IFN-I and IL-12 were
shown to induce the high-affinity IL-2 receptor (CD25) on NK cells via a STAT4-dependent
mechanism [44]. However, the consequence of these cytokines on CD25 expression was stud-
ied only for NK cell proliferation during MCMV infection. The role of proliferation, per se, in
MCMV control is unclear because Ly49H-specific proliferation is detectable after Ly49H-
dependent MCMV control had already occurred [39]. By contrast, we report here that both
cytokines are required for Ly49H activation receptor-dependent killing and are critical for
MCMV control.
The roles of IL-12 and IFN-I during MCMV infection also have been extensively studied by
others [23]. Initially, it was reported that NK cell-dependent IFNγ production required an IL-
12-mediated pathway while cytotoxicity was enhanced through IFN-I signaling during MCMV
infection. Another role of IFN-I is to promote chemotaxis of NK cells to virally infected livers
[45] but Ly49H-mediated effects are generally not observed in the liver [3]. More recent char-
acterization of both IL-12 and IFN-I dependent pathways intrinsic to NK cells during MCMV
infection has demonstrated non-redundant effects on cytotoxicity, IFNγ production, and sur-
vival [41]. IFN-I signaling clearly promoted NK cell cytotoxicity but it was not previously clear
if these effects were Ly49H-dependent or Ly49H-independent. Here we report that IL-12 and
IFN-I pathways act redundantly to enhance Ly49H-dependent cytotoxicity.
IFNα was previously reported to only modestly induce GzmB in NK cells [31]. However,
IFNα and IFNβ are both induced during acute MCMV infection with similar kinetics [46].
Here we show IFNβ is much more potent than IFNα in inducing GzmB in NK cells, consistent
with reported increased immune responses to IFNβ as compared to IFNα [47]. IFNβ only
requires the IFNAR1 subunit, whereas IFNα requires both the IFNAR1 and IFNAR2 subunits
[48], which may provide a molecular explanation to the observed differences between both
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IFN-I molecules. Regardless, our studies suggest that IFNβmay be the primary IFN-I in medi-
ating NK cell mediated viral control during acute MCMV infection, but due to the large num-
ber of IFN-I molecules, additional work will be needed to determine if a specific IFN-I
molecule is critical for Ly49H-dependent control.
Finally, there are clear parallels between our work and cytokine-involvement in T cell
responses, as cytokines have been described to act as a “third” signal, in addition to T-cell
receptor and co-stimulatory molecule engagement during T-cell priming as well as prolifera-
tion and survival [49]. This third signal has been found to be essential for priming of CD8+ T
cells as well as enhancing their effector functions [50]. Analogous to the effect of cytokines on
T-cell expansion, IL-12 and IL-15 have been described to play a central role in proliferation
and survival of NK cells [51, 52]. Our data now show that other cytokines provide crucial sig-
nals to NK cells for activation receptor-mediated cytolytic functions, beyond that of NK cell
proliferation and survival.
In conclusion and based on results reported here, we propose the following model, where
NK cells require two signals for efficient cytolytic effector function. Signaling through a cyto-
kine receptor on the NK cell itself, which is provided by IL-12 or IFN-I in the case of MCMV
infection, results in the accumulation of cytotoxic effector molecules, including GzmB. Activa-
tion receptor recognition of target cells through ligands, such as m157, signals NK cell release
of cytotoxic cargo, ultimately leading to killing of the (virus-infected) target cell and MCMV
control. In the absence of cytokine stimulation, Ly49H activation may occur, resulting in gran-
ule exocytosis, but the NK cells will be impotent killers because cytotoxic effector molecules,
such as GzmB, are poorly expressed. Conversely, absence of activation receptor stimulation
leads to poor NK cell control. Thus, NK cells require two intrinsic signals to mediate effective
cytotoxic control of viral infection.
Materials and Methods
Mice
B6 (and congenic Ly5.2 B6) mice were purchased from either the National Cancer Institute (Fre-
drick, MD) or Charles River Laboratories (Wilmington, MA). The following strains were pur-
chased from Jackson Laboratory: IL-12Rβ2-/- (003248), IL-12p40-/- (002693), Prf1-/- (002407),
IFNγ-/- (002287), IFNγR-/- (003288), IL-18-/- (004130), Lyst (000629), and RAG1-/- (002216).
Jinx mice, harboring a mutation in UNC13D, and TRIF-/- mice, were both provided by B. Beu-
tler (Scripps Research Institute, La Jolla, CA). MyD88-/- mice were provided by S. Akira (Osaka
University, Osaka, Japan) or purchased through the Jackson Laboratory (009088). DAP12 KI
mice were provided by E. Vivier (CNRS-INSERM-Universite de la Mediterranee, France).
DAP12-/- and DAP10-/-DAP12-/- [53] mice were provided by T. Takai. DAP10-/- [54] mice
were provided by M. Colonna. Batf3-/- [43] mice were provided by K. Murphy. IFNAR1-/- [55],
m157-Tg [36] and Ly49H-deficient B6.BxD8 [56] mice were generated and maintained in our
laboratory. The Speed Congenics Facility of the Rheumatic Diseases Core Center at Washington
University assisted in backcrossing mice to the B6 background using a marker-assisted approach.
Standard breeding strategies were used to generate double deficient MyD88-/-TRIF-/- mice, IL-
12p40-/-IFNαβR-/- mice, and IL-12Rβ2-/-IFNαβR-/- mice. All mice used were generated on or
backcrossed to the C57BL/6 (B6) genetic background. All mice were used in accordance with
institutional guidelines for animal experimentation.
Viral infection and generation of Δm157-MCMV
The salivary gland propagated MCMV stocks were generated from purified and sequenced
clones. Virus was inoculated via the intraperitoneal (IP) route in a total volume of 200μl PBS.
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The complete genomic sequence for the strain designated WT1 was previously published [57].
To generate an escape virus deficient in m157 expression, WT1 MCMV was passaged in a T
cell-deficient host (TCRbd-/-; Jackson Laboratory, 002122) for 3 weeks, followed by plaque
purification of spleen-derived virus and subsequent assessment of Ly49H-engagement as
described previously [10]. The entire genome of the Δm157-MCMV was sequenced (HiSeq,
Illumina) and a single G to T nucleotide substitution at position 502 of m157 (numbering rela-
tive to translational start codon) was identified as the only deviation in the 230kb sequence
compared with WT1, consistent with our prior studies indicating the stability of MCMV and
the role of Ly49H in specifically selecting mutations in m157 [10, 57]. The base substitution
results in a premature stop codon (GAA to TAA) within the m157 ORF. An in vitro LacZ-
based Ly49H-reporter assay [5] confirmed that the Δm157-MCMV lacked m157 expression
and was unable to engage the Ly49H receptor. A multi-step growth curve [58] was performed
on NIH 3T12 (ATCC CCL-164) fibroblasts (multiplicity of infection [MOI] = 0.1). Viral
genome copies quantified from cell lysates and culture supernatants demonstrated that replica-
tion of Δm157-MCMV was equivalent to WTMCMV (S1J Fig). To generate an inoculum con-
taining 10% Δm157-MCMV, 2000 PFU of Δm157-MCMV was mixed with 18000 PFU of WT1
virus, both of salivary gland origin.
Viral genome quantification
Genomic DNA was prepared from mouse tissues, cell lysates, and culture supernatants using
the Puregene extraction kit (Qiagen) following manufacturer recommendations. DNA was
adjusted to achieve a concentration between 20–50ng/μl. Each qPCR reaction consisted of 5μl
of TaqMan Universal PCR Master Mix, No AmpErase UNG (Life Technologies, #4324018),
2μl of organ DNA, 0.5μl of a 20X primer/probe mixture (PrimeTime qPCR Assay, IDT) with
sequences as described in S1 Table, and 2.5μl water. This is done for both IE1 and actin in sepa-
rate reactions. Amplification was performed on the AppliedBiosystems StepOne Plus qPCR
instrument (Life Technologies). Each reaction was run in duplicate and quantified against a
standard curve to ensure linearity, sensitivity, and enable comparison between independent
runs. The standard curve efficiencies were consistently near 100%. Data were analyzed by first
generating a ratio of MCMV IE DNA copies/murine actin DNA copies. As actin appears to be
present in about a 1000-fold excess over IE1, multiplying the resulting ratio by 1000 closely
reflects PFU values obtained by standard plaque assays.
Viral escape frequency determination
To calculate the frequency of escape virus (Δm157-MCMV) following infection, genomic DNA
was prepared as for viral genome quantification. The primer/probe mixtures (S1 Table) con-
tained Taqman probes for both WT and m157-deficient alleles in a single tube, differentiated
via the dye conjugate (Custom TaqMan SNP Genotyping Assay, Life Technologies, #4332075).
To validate the specificity and dynamic range of the Taqman-based genotyping assay, we ini-
tially determined the ratio of SNP-specific product to WT product using predetermined mix-
tures of 1%, 5%, 10%, 25%, 50%, 75%, and 100% Δm157-MCMV. The ΔΔCT (cycle threshold)
was calculated as a difference between the CT of the 100% Δm157-MCMV sample and the
individual reference samples. A second-order polynomial (quadratic) function to describe the
slope of the line through these points allowed accurate determination of Δm157-MCMV fre-
quencies between 5% and 75% (S1K Fig). In validation assays, the percent of Δm157 that was
greater than 75% could not be quantified due to cross-reactivity with the Taqman probe for
WTMCMV. Therefore 75% was considered the limit of quantification (L).
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Antibody depletions
Purified 3D10 (α-Ly49H), PK136 (α-NK1.1), and MAR (isotype controls) were obtained from
hybridomas purified by the Rheumatic Diseases Core Center Protein Purification and Produc-
tion Facility. MAR1-5A3 (α-IFNAR1) [59] and GIR-208 (IFNAR1 isotype control, [60] were
previously described. Antibodies was injected IP at a dose of 200μg per mouse 24hrs (α-
Ly49H) or 48 hrs (α-NK1.1) prior to infection, or 2mg (α-IFNAR1) per mouse 24 hrs prior to
infection.
Reagents and cell preparation
Fluorescent-labeled antibodies used were, anti-NK1.1 (clone PK136), anti-NKp46 (29A1.4),
anti-CD3 (145-2C11), anti-CD19 (eBio1D3), anti-CD45.1 (A20), anti-CD45.2(104), anti-
CD107a (eBio1D4B), anti-perforin (eBioOMAK-D) were purchased from Affymetrix, anti-
granzyme B (GB12) and isotype control were purchased from Life Technologies, and biotiny-
lated anti-Ly49H (clone 3D10) was produced as described earlier [36]. IFNα4 and IFNβ were
purchased from PBL Assay Science, IL-6, IL-12, IL-15 from Peprotech, IL-18 fromMBL, and
IL-2 was produced in-house. NK cells were purified from RAG1-/- splenocytes to a purity
>95% using CD49b microbeads (Miltenyi Biotec) according to manufacturer’s instructions.
m157-Tg murine embryonic fibroblasts were isolated from day 11.5–13.5 embryos, WT
embryos from the same pregnant female served as in utero controls.
Flow cytometry
All cells were first stained with fixable viability dye (Affymetrix), followed by surface staining
with directly conjugated antibodies or in two steps using streptavidin-PE (Becton Dickinson)
in 2.4G2 hybridoma supernatant to block Fc receptors and washed with PBS with 0.5% BSA
and 0.02% Sodium Azide (PBA). Subsequently, samples were fixed and stained intracellularly
using Cytofix/Cytoperm kit according to manufacturer’s protocol (BD Biosciences). Samples
were analyzed by flow cytometry using FACSCanto (BD Biosciences) and FACScan with DxP6
upgrade (Cytek). Data was analyzed using FlowJo software (Tree Star). NK cells were defined
as Viability-NK1.1+CD3-CD19-.
In vitro stimulation assays
Freshly isolated splenocytes were co-cultured with congenic CD45.1/2 or CFSE-labeled
m157-Tg or littermate control splenocytes at a 1:1 ratio in the presence or absence of cytokine
at the concentration indicated. For degranulation assays anti-CD107a and monensin (Affyme-
trix) was added after 1 hour and the reaction was stopped 5–8 hours later by the addition of
PBA. For GzmB staining, samples were stained after 16–20 hours after initiation of co-culture.
For stimulation assays with pure NK cells, NK cells were co-cultured with MEF at a 1:1 ratio.
In vivo cytotoxicity assay
Target splenocytes isolated from Ly5.1xLy5.2 m157-Tg animals were labeled with 1μMCFSE
(Life technologies) and Ly5.1xLy5.2 WT littermate controls were labeled with 5μMCFSE.
CFSElow and CFSEhigh target cells were mixed at a 1:1 ratio and 2-3x106 target cells were
injected i.v. into naïve or treated mice as described. After 3 hours challenge splenocytes were
harvested and stained. The ratio of CFSElow and CFSEhigh viable CD19+ cells was determined
by flow cytometry. Target cell rejection was calculated using the formula [(1−(Ratio(CFSElow:
CFSEhigh)sample/Ratio(CFSE
low:CFSEhigh)control)) × 100]. Average of 2–3 NK1.1-depleted mice
and input mixture served as control.
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Statistical analysis
Statistical analysis was performed using Prism (GraphPad software). Unpaired, two-tailed Stu-
dent's t-tests were used to determine statistically significant differences between experimental
groups. Error bars in figures represent the SEM.
Ethics statement
This study was carried out in strict accordance with the recommendations in the Guide for the
Care and Use of Laboratory Animals of the National Institutes of Health. The protocol was
approved by the Animal Studies Committee at Washington University School of Medicine
under animal protocol 20130049A2.
Supporting Information
S1 Fig. Selection of m157-deficient virus during a dual infection assay is dependent upon
the NK cell Ly49H activation receptor. (A,C-G,I) Viral titers and (B,H) viral escape (Δm157)
frequency determined five days after a mixed MCMV infection with 2e4 PFU/mouse in spleen
(A-G) and liver (H,I). In (B) and (C), 1e6 PFU/mouse was inoculated as indicated. (A) α-
NK1.1 (or isotype control) was administered 48hrs prior to infection. (G) Statistical analysis
performed by comparing values fromWTmice with genetically modified or antibody-treated
mice. For all panels, individual points represent a single mouse. L = Limit of quantification
(75%). I = Input frequency (10%). (J)Multi-step growth curve of NIH 3T12 fibroblasts initially
infected with a multiplicity of infection (MOI) of 0.1 with the indicated virus stocks. Virus was
isolated from both supernatant and cell lysates and quantified via qPCR. (K) Assessment of
known mixtures of WT and m157-deficient virus using a Taqman genotyping served as stan-
dards to quantify results. A trendline is depicted with the quadratic expression that defines the
slope and the indicated R-squared value. The ΔΔCT refers to the log-2 transformed qPCR cycle
threshold (CT) of the Δm157 Taqman probe subtracted from the WT probe, with 100%
Δm157 as the comparator (i.e. for 100% Δm157, ΔΔCT = 0).
(EPS)
S2 Fig. Increased GzmB production in Ly49H+ NK cells independent of Ly49H triggering.
(A) GzmB levels in Ly49H+ versus Ly49H- NK cells stimulated in vitro as in Fig 4A. (B) GzmB
levels in Ly49H+ versus Ly49H- splenic NK cells after MCMV infection in vivo as in Fig 5C.
(EPS)
S3 Fig. IFNAR1-/-xIL12Rβ2-/- NK cells have reduced cytotoxic activity at steady state, but
are fully functional in degranulation and GzmB production. (A) GzmB in NK and percent-
age of NK cells in mice treated as in Fig 5A. (B)m157-specific rejection as in Fig 7. (C) Expres-
sion of CD27 and CD11b onWT versus double deficient NK cells. (D) GzmB response in NK
cells to cytokine stimulation as in Fig 4. (E) Degranulation in NK cells in response to m157 and
cytokine stimulation as in Fig 3.
(EPS)
S1 Table. Primer and probe sequences for quantitative PCR amplifications.
(TIF)
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